Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 9.72B 1.45B 1.25B 1.18B 1.07B 2.01B 138B 2.02B 14.04B 5.4B 70.42B 5.44B 5.32B 223B P/E 2026 *
14.3x
P/E 2027 * 12.9x
Enterprise Value 9.72B 1.45B 1.25B 1.18B 1.07B 2.01B 138B 2.02B 14.04B 5.4B 70.42B 5.44B 5.32B 223B EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.11x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day-1.64%
1 week-4.03%
Current month-3.91%
1 month-4.94%
3 months-7.13%
6 months-15.76%
Current year-20.96%
1 week 22.05
Extreme 22.05
23.06
1 month 22.05
Extreme 22.05
23.99
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
32.2
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 2019-05-27
Director of Finance/CFO 49 2023-12-27
Corporate Officer/Principal 40 2021-08-18
Director TitleAgeSince
Chairman 64 2010-03-15
Director/Board Member 48 2019-05-27
Director/Board Member 40 2022-06-13
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-4.03%-18.04%-0.27% 1.42B
+1.86%+1.08%+51.84%+92.02% 994B
+1.33%+0.39%+52.29%+65.00% 640B
+1.50%+5.35%+20.44%+70.59% 454B
+4.95%+2.97%+39.82%+40.28% 337B
+2.03%-8.35%+17.73%+26.03% 261B
+3.14%+1.21%+6.78%+12.71% 246B
+0.09%-3.69%+38.00%+44.37% 204B
+1.48%-5.77%-20.67%-58.75% 190B
+0.75%-1.00%+29.00%+87.67% 178B
Average +1.55%-5.50%+21.72%+37.96% 350.62B
Weighted average by Cap. +1.94%-4.42%+35.08%+57.67%

Financials

2026 *2027 *
Net sales 4.2B 626M 539M 511M 463M 868M 59.79B 873M 6.06B 2.33B 30.42B 2.35B 2.3B 96.12B 4.61B 686M 591M 560M 508M 952M 65.58B 957M 6.65B 2.56B 33.37B 2.58B 2.52B 105B
Net income 668M 99.5M 85.73M 81.17M 73.57M 138M 9.51B 139M 964M 371M 4.84B 374M 365M 15.28B 740M 110M 94.97M 89.93M 81.51M 153M 10.53B 154M 1.07B 411M 5.36B 414M 405M 16.93B
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
26-09-14 CN¥22.55 +1.90% 3,746,100
26-09-11 CN¥22.13 -1.64% 4,113,563
26-09-10 CN¥22.50 -0.66% 3,259,540
26-09-09 CN¥22.65 -1.31% 3,386,300
26-09-08 CN¥22.95 +0.44% 3,510,480
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.13CNY
Average target price
37.74CNY
Spread / Average Target
+70.56%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!